Any nephrotoxicity ‐ Ag dosing regimen (Copy) · patients with proven or suspected infection
Teicoplanin probably leads to lower nephrotoxicity compared with vancomycin (moderate certainty).
1 finding from 1 review
Clinical efficacy ‐ cure or improvement at · patients with proven or suspected infection
Teicoplanin showed no clear difference in clinical cure or improvement compared with vancomycin (moderate certainty).
1 finding from 1 review
Microbiological cure · patients with proven or suspected infection
Teicoplanin showed no clear difference in microbiological cure compared with vancomycin (moderate certainty).
1 finding from 1 review
Renal failure needing dialysis2 · patients with proven or suspected infection
1 finding from 1 review
All‐cause mortality · patients with proven or suspected infection
Teicoplanin showed no clear difference in mortality compared with vancomycin (low certainty).
1 finding from 1 review
Rash · patients with proven or suspected infection
Teicoplanin probably leads to lower cutaneous rash compared with vancomycin (moderate certainty).
1 finding from 1 review
Total adverse events · patients with proven or suspected infection
It is very uncertain whether teicoplanin changes total adverse events compared with vancomycin (very low certainty).
1 finding from 1 review
Symptomatic Cure · patients with Clostridium difficile‐associated diarrhoea in adults
It is very uncertain whether teicoplanin changes symptomatic Cure compared with vancomycin (very low certainty).
1 finding from 1 review
Bacteriologic Cure · patients with Clostridium difficile‐associated diarrhoea in adults
It is very uncertain whether teicoplanin changes bacteriologic Cure compared with vancomycin (very low certainty).
1 finding from 1 review
All‐cause mortality during hospital stay and all‐cause mortality at 1 year · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cure · people with endocarditis due to Staphylococcus aureus in drug abusers
Glycopeptide (vancomycin or teicoplanin) plus aminoglycoside… may leads to lower cure compared with beta‐lactam (cloxacillin) plus aminoglycoside (gentamicin) (low certainty).
1 finding from 1 review
Adverse events · people with endocarditis due to Staphylococcus aureus in drug abusers
It is very uncertain whether glycopeptide (vancomycin or teicoplanin) plus aminoglycoside… changes adverse events compared with beta‐lactam (cloxacillin) plus aminoglycoside (gentamicin) (very low certainty).
1 finding from 1 review
Congestive heart failure · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Septic embolism · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for cardiac surgical interventions · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uncontrolled infection · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Vancomycin versus teicoplanin (paediatric cardiac surgery) · surgical patients
1 finding from 1 review
Intervention not reported
Vancomycin versus teicoplanin (paediatric cardiac surgery) · surgical patients
1 finding from 1 review